Skip to content

Amritprash Ghrit Uttar Basti In Anovulation

Clinical Evaluation Of Amritprash Ghrit Uttar Basti In Stree Vandhyatva Anovulatory Cycle - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113924
Enrollment
30
Registered
2026-07-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N970- Female infertility associated withanovulation

Interventions

None listed

Sponsors

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All primary and secondary cases of infertility due to anovulation

Exclusion criteria

Exclusion criteria: 1. Congenital anatomical defect. 2. Infertility due to severe infection. 3. Uncontrolled hypertension, diabetes mellitus, cardiac disorders. 4. Hyper-prolactinemia, Thyroid Dysfunction, Hypothalamic dysfunction . 5. Pre-mature ovarian insufficiency/failure, Ovarian resistance. 6. Bilateral Tubal blockage

Design outcomes

Primary

MeasureTime frame
Follicles getting rupture as seen in TVSTimepoint: 3 months The drug trial will be given for 3 days for 3 consecutive menstrual cycle after the cessation of menses

Secondary

MeasureTime frame
Improvement in menstrual cycle parameters Dominant follicle size Endometrial thicknessTimepoint: 3 months The drug trial will be given for 3 days for 3 consecutive menstrual cycle after the cessation of menses

Countries

India

Contacts

Public ContactDr Anil Kumar

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan Haridwar

pacoffice@divyayoga.com9997811414

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026